CBDVa/CBDa – The new generation of cannabinoids with exceptional therapeutic potential
Christine de Vogel
CBDVa/CBDa – The new generation of cannabinoids with exceptional therapeutic potential
🌿 CBD& Herb Selection
Every month we highlight a powerful product from our range – this time: CBDVa/CBDa 10% oil from CBD Spain.
CBD Spain introduces an innovative extract: CBDVa/CBDa 10% , a rare and powerful blend of two acidic cannabinoids with impressive therapeutic potential. This extract was developed and based on years of research by Peter Vermeul , researcher and producer.
Why This Extract is Different
Contains 1:1 CBDVa and CBDa
Acidic : pharmacologically more active than the “heated” (neutral) forms
100% natural and pure – no synthetic additives
Unique on the market
Therapeutic potential: what does science say?
🧠 Neurological
Epilepsy, ASD, ADHD : CBDVa affects ion channels and GPR55 receptors, relevant for stimulus conduction in the brain.
Mood & Nausea : CBDa binds to the 5-HT1A (serotonin receptor) and has been shown in studies to be more potent than CBD in treating nausea, anxiety, and depression.
🔥 Inflammation & pain
CBDa inhibits COX-2 and pro-inflammatory cytokines: similar to NSAIDs, but plant-based.
Suitable for arthritis, IBD, fibromyalgia , among others.
🌿 Antifungal
CBDa has proven antifungal effects – effective against Candida and other fungi.
Can be supportive for skin problems or intestinal flora issues with a fungal component.
Who is this extract intended for?
From a scientific perspective, this extract is ideally suited for people with:
Epilepsy, ADHD, autism, mood disorders
Chronic inflammation and pain
Fungal infections (skin, intestine)
Nausea or anxiety
Scientific source
Want to learn more about the effects of CBDVa and CBDa? Download the full research paper by Peter Vermeul (CBD Spain) here.